FATE — Fate Theraputics

Ownership history in Bruce & Co., Inc.  ·  25 quarters on record

This page tracks every 13F SEC filing in which Bruce & Co., Inc. reported a position in Fate Theraputics (FATE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.31% (2020 Q4)
Avg. % of fund
0.44%
First filed
2019 Q4
Last filed
2025 Q4
Quarters held
25
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 729,188 — 0% 0.22% $716K $0.98
2025 Q3 ADDED 729,188 +300,000 +69.9% 0.28% $919K $1.26
2025 Q2 REDUCED 429,188 -120,812 -22.0% 0.16% $481K $1.12
2025 Q1 ADDED 550,000 +200,000 +57.1% 0.14% $434K $0.79
21 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    FATE price (monthly, adj. close)

Other funds also holding FATE

As of 2025 Q4 — sorted by position size

Redmile Group, LLC 3Y 7Y 0.93% JOHNSON & JOHNSON 3Y 0.6% Knott David M Jr 3Y 0.17% Monaco Asset Management SAM 3Y 0.14% DAFNA Capital Management LLC 3Y 7Y 0.13% Privium Fund Management B.V. 3Y 0.07% Vestal Point Capital, LP 0.06% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.06% Parametrica Management Ltd 3Y 7Y 0.03% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.02%
← Back to Bruce & Co., Inc. Holdings